The content originally appeared on: Trinidad and Tobago Newsday News Trinidad and Tobago-born Tonya Villafana is the global franchise head, vaccines and immune therapies at AstraZeneca, the British-Swedish multinational pharmaceutical and biotechnology company and developer of the Oxford/AstraZeneca covid19 vaccine. A sectional vice president at AstraZeneca, one of the developers of the WHO-approved covid19 vaccines will take a seat at the Ansa McAl Board of Directors table. She was voted in at the Annual General Meeting held virtually on Thursday. […]
